Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study of Galcanezumab (LY2951742) in Participants With Migraine Headache

ClinicalTrials.gov ID: NCT02163993

Public ClinicalTrials.gov record NCT02163993. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 26, 2026, 9:26 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Patients With Episodic Migraine

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The main purpose of this study is to evaluate whether the study drug known as galcanezumab is safe and effective in the prevention of migraine headaches.

Study identification

NCT ID
NCT02163993
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
414 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 6, 2014
Primary completion
Aug 18, 2015
Completion
Feb 11, 2018
Last update posted
Nov 22, 2018

2014 – 2018

United States locations

U.S. sites
40
U.S. states
20
U.S. cities
37
Facility City State ZIP Site status
Clinical Research Advantage Gilbert Arizona 85234 —
21st Century Neurology Phoenix Arizona 85004 —
Arizona Research Center Phoenix Arizona 85023 —
Pharmacology Research Institute, Long Beach Encino California 91316 —
Collaborative Neuroscience Network - CNS Long Beach California 90806 —
Pharmacology Research Institute, Long Beach Los Alamitos California 90720 —
Pharmacology Research Institute, Long Beach Newport Beach California 92660 —
Desert Valley Research Rancho Mirage California 92270 —
Artemis Institute for Clinical Research San Diego California 92013 —
Medical Center for Clinical Research San Diego California 92108 —
San Francisco Clinical Research Center San Francisco California 94109 —
California Medical Clinic for Headache Santa Monica California 90404 —
Alpine Clinical Research Center Boulder Colorado 80304 —
New England Institute for Clinical Research Stamford Connecticut 06905 —
Avail Clinical Research LLC DeLand Florida 32720 —
Florida Clinical Research Center LLC Maitland Florida 32751 —
Renstar Medical Research Ocala Florida 34471 —
Psychiatric Inst of Florida-Clinical Neuroscience Solutions Orlando Florida 32801 —
Premiere Research Institute at Palm Beach Neurology West Palm Beach Florida 33407 —
Otri-Med Corporation Edgewood Kentucky 41017 —
PharmaSite Research Inc Baltimore Maryland 21208 —
Boston Clinical Trials Inc Boston Massachusetts 02131 —
Michigan Head, Pain and Neurological Institute Ann Arbor Michigan 48104 —
Westside Family Medical Center Kalamazoo Michigan 49009 —
ClinVest Springfield Missouri 68507 —
Mercy Health Research St Louis Missouri 63141 —
Albuquerque Clinical Trials Albuquerque New Mexico 87102 —
Island Neuro Associates,PC Plainview New York 11803 —
Rochester Clinical Research, Inc. Rochester New York 14609 —
PharmQuest Greensboro North Carolina 27408 —
PMG Research of Winston-Salem, LLC Winston-Salem North Carolina 27103 —
Summit Research Network Inc Portland Oregon 97210 —
Thomas Jefferson University Philadelphia Pennsylvania 19107 —
Coastal Carolina Research Center, Inc. Mt. Pleasant South Carolina 29464 —
CNS Health Care Memphis Tennessee 38119 —
FutureSearch Trials Austin Texas 78731 —
DermResearch Austin Texas 78759 —
Northwest Clinical Research Center Bellevue Washington 98007 —
North Seattle Womens Group Seattle Washington 98105 —
Dean Foundation for Health Research and Education Middleton Wisconsin 53562 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02163993, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 22, 2018 · Synced Sep 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02163993 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →